A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to
control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have …

Background Vaccines to prevent coronavirus disease 2019 (Covid-19) are urgently needed.
The effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines on …

Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus
that since its emergence in 2012 has caused outbreaks in human populations with case-…

Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, has been
implicated in the development of Kaposi's sarcoma (KS) and several B-cell lymphoproliferative …

Public health measures have successfully identified and contained outbreaks of the severe
acute respiratory syndrome (SARS) coronavirus (SARS-CoV) 1 , 2 , 3 , 4 , 5 , but concerns …

Influenza viruses pose a significant threat to the public and are a burden on global health
systems 1 , 2 . Each year, influenza vaccines must be rapidly produced to match circulating …

The antibody response to influenza is primarily focused on the head region of the hemagglutinin
(HA) glycoprotein, which in turn undergoes antigenic drift, thus necessitating annual …

The severe acute respiratory syndrome coronavirus (SARS-CoV) synthesizes several putative
viral envelope proteins, including the spike (S), membrane (M), and small envelope (E) …

Chikungunya virus (CHIKV) has infected millions of people in Africa, Europe and Asia 1 , 2
since this alphavirus reemerged from Kenya in 2004. The severity of the disease and the …

The rapid dissemination of the 2009 pandemic influenza virus underscores the need for
universal influenza vaccines that elicit protective immunity to diverse viral strains. Here, we show …